The FDA-funded RCT DUPLICATE demonstration has found that real world studies based on observational claims data “can come to similar conclusions as trials when we’re able to emulate them well,” Brigham and Women’s Hospital associate professor Shirley Wang reported during a meeting on project results hosted by the Duke Margolis Center for Health Policy on 10 May.
However, “it’s more challenging to emulate trials that are designed with many constraints to show effects under ideal conditions,” Wang continued. “Unsurprisingly, we had greater success replicating results in trials...